Le Lézard
Classified in: Environment, Health, Science and technology, Covid-19 virus
Subject: PSF

Beyond Medical Provides Update on Made in Canada Medical Face Masks and Start of Manufacturing of N95 Face Masks

VANCOUVER, BC, Feb. 23, 2021 /CNW/ - Beyond Medical Technologies Inc. ("Beyond Medical" or the "Company") (CSE: DOCT) (FSE: 7FM4) thru its subsidiary Micron Technologies Inc is pleased to provide the following corporate update.

Micron Technologies, the company's wholly owned subsidiary has been manufacturing and selling medically certified three ply face masks in the colour blue and also in black since August 2020. The company is selling out all the inventory that it can manufacture on three shifts a day and is looking to bring in additional manufacturing equipment and personnel. Parties wishing to purchase our masks online can do so at: www.micronti.com

There is an ongoing shortage of N95 medical grade masks for frontline first responders across North America.
Ranvir Gujral stated on NPR radio "But fewer companies shifted to making N95 masks, which are far more complicated, and they're in short supply. Nurses and doctors are re-using masks over and over again. Some small medical practices can't even find supplies they can afford" 

Micron Technologies has initiated manufacturing of made in Canada N95 Model 8800 masks at our state-of-the-art manufacturing facility in Delta, BC.. The Company is currently manufacturing and distributing under its Class 1 Medical Devices pursuant to the Company's Medical Device Establishment License from Health Canada and Medical Device Registration with the US Food and Drug Administration.

The Company's N95 Model 8800 respirators are currently CSA and FDA approved and  undergoing testing and awaiting medical-grade certification from the National Institute for Occupational Safety and Health (NIOSH). N95 masks are the gold standard of personal protective equipment, particularly among healthcare professionals. They provide the highest level of protection for the user and those in close proximity to infected patients. N95 masks are both high in demand and low in supply worldwide. It is the intent of the Company to have its N95 respirators CSA, FDA and NIOSH certified and sold to medical professionals and citizens to help stop the spread of COVID-19.

About Beyond Medical

Beyond Medical is an industrial/technology company with a manufacturing facility located in Delta, British Columbia. The Company is developing its Organivore and Pharmavore waste digesters using its proprietary technology. The Company, through its subsidiary Micron Technologies, is also manufacturing medical grade facemasks compliant with ASTM F2100 Standards. Beyond Medical currently has a non binding LOI to acquire Kayan Health

About Kayan Health

Kayan Health's proprietary AI-powered health communications platform helps doctors streamline communications with their patients and remotely monitor them. Additionally, Kayan Health's proprietary platform allows patients to schedule virtual consultations with their physicians and communicate with them through chat, audio and video calls. The platform also integrates with wearable devices and diagnostic tools that delivers both patients and doctors with greater visibility into the patient's health and provides them with proactive automated alerts such as elevated blood pressure and heart rates. Storing all this data in a holistic patient profile that is integrated with the clinic's electronic health systems ? ensuring their patients' health records are up to date, accessible by all, helps deliver better care and enables clinics to generate more revenue.

Kayan Health's platform has already been deployed in multiple clinics in the United States and is projected to reach $5M in revenue by 2022. Kayan Health's proprietary platform was developed by the founders of HeyDoc!, a telehealth app launched in 2016 that had supported over 3,000 patients globally. Kayan Health is a privately held company based in Toronto, Ontario.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the transactions proposed herein and has neither approved nor disapproved the contents of this press release.


All information contained in this news release with respect to the Company and Kayan Health was supplied by the parties, respectively, for inclusion herein, and the Company and its respective directors and officers have relied on Kayan Health for any information concerning such party.

This release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements.Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

SOURCE Beyond Medical Technologies Inc.

These press releases may also interest you

at 09:50
The "CRISPR Gene Detection and Diagnostic Markets by Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides - 2021 to 2025" report has been added to ResearchAndMarkets.com's offering. The market has just gotten...

at 09:45
HMP Global, a leading healthcare event and education company, today announced the agenda and faculty lineup for its inaugural Great Debates & Updates in Women's Oncology, taking place online April 23-24 via the company's VRTX virtual events platform....

at 09:35
The last 12-18 months has dawned a new era in health, along with new expectations of companies across the health spectrum. Adding to the already fast-paced rate of change over the last two decades, necessity-driven implementation due to Covid-19 has...

at 09:30
TriSalus Life Sciences®, an emerging immuno-oncology company committed to transforming outcomes for patients with liver and pancreatic tumors, today announced data presented at the American Association of Cancer Research showing that regional...

at 09:30
Government of Canada officials will hold a technical briefing to provide an update on the AstraZeneca COVID-19 vaccine. Officials will be available to answer questions from the media following their remarks. DateApril 14, 2021 Time11:00 AM (EDT)...

at 09:30
The medical cannabis market has made some remarkable accomplishments in the past few years with the launch of innovative products. The clinical trials and approval of some cannabis-infused products have opened up the market for cannabinoid-based...

News published on 23 february 2021 at 09:30 and distributed by: